Dehydroepiandrosterone (DHEA) treatment of depression (Q38457551)

3 September 2017

Dehydroepiandrosterone (DHEA) treatment of depression (English)

1 reference

3 September 2017

1

Wolkowitz OM

1 reference

3 September 2017

Reus VI

2

1 reference

3 September 2017

Roberts E

3

1 reference

3 September 2017

Manfredi F

4

1 reference

3 September 2017

Chan T

5

1 reference

3 September 2017

Raum WJ

6

1 reference

3 September 2017

Ormiston S

7

1 reference

3 September 2017

Johnson R

8

1 reference

3 September 2017

Canick J

9

1 reference

3 September 2017

Brizendine L

10

1 reference

3 September 2017

Weingartner H

11

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

3 September 2017

Biological Psychiatry

1 reference

3 September 2017

41

1 reference

3 September 2017

3

1 reference

3 September 2017

311-318

1 reference

Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. The Obesity Research Program.

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

An Experimental Study of Social Isolation of Elderly People: Psychoendocrine and Metabolic Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Dehydroepiandrosterone: antiglucocorticoid action in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Neuroendocrine correlates of the type A behavior pattern: a review and new hypotheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Psychological, behavioral and biochemical risk factors for coronary artery disease among American and Italian male corporate managers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Dehydroepiandrosterone-sulfate/cortisol ratio in panic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

A PRELIMINARY INVESTIGATION OF STEROID EXCRETION IN DEPRESSED PATIENTS BEFORE AND AFTER ELECTROL-CONVULSIVE THERAPY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Elevated serum dehydroepiandrosterone sulfate levels in practitioners of the Transcendental Meditation (TM) and TM-Sidhi programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

The relation between dominance, anger, and hormones in normally aging men: results from the Massachusetts Male Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Dehydroepiandrosterone and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Severe psychosis and the adrenal androgens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

A process dissociation framework: Separating automatic from intentional uses of memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Exploring the connections between platelet monoamine oxidase activity and behavior. II. Impulsive personality without neuropsychological signs of disinhibition in air force pilot recruits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Effect of dehydroepiandrosterone on hereditary angioedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Dehydroepiandrosterone sulfate alters synaptic potentials in area CA1 of the hippocampal slice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

7 January 2021

Steroids and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Plasma dehydroepiandrosterone sulfate in nursing home men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Further studies on endocrine treatment in adolescence and early adult life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Treatment of inadequate personality in juveniles by dehydroisoandrosterone; preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Use of dehydroisoandrosterone in psychiatric treatment; a preliminary survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Use of dehydroisoandrosterone in psychiatric practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

A psychobiologic analysis of cognitive failures. Structure and mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

24 Hour Urinary Dehydroepiandosterone Sulfate in Unipolar Depression Treated with Cognitive and/or Pharmacotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

An open study of dehydroepiandrosterone in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Ketoconazole administration in hypercortisolemic depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

Cognitive effects of corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900043-1

10.1016/S0006-3223(96)00043-1

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference